Effects of antirheumatic gold compounds on the conversion of xanthine dehydrogenase to oxidase in rabbit liver cytosol in vitro.

[1]  M. Zuber,et al.  Elevated levels of xanthine oxidase in serum of patients with inflammatory and autoimmune rheumatic diseases , 1993, Inflammation.

[2]  K. Kataoka,et al.  Induction of Cellular Antioxidative Stress Genes through Heterodimeric Transcription Factor Nrf2/Small Maf by Antirheumatic Gold(I) Compounds* , 2001, The Journal of Biological Chemistry.

[3]  S. Sakuma,et al.  N-ethylmaleimide inhibits xanthine oxidase activity with no detectable change in xanthine dehydrogenase activity in rabbit liver. , 2000, Life sciences.

[4]  O. Førre,et al.  Rheumatoid arthritis and metal compounds--perspectives on the role of oxygen radical detoxification. , 1998, The Analyst.

[5]  M. Benboubetra,et al.  Xanthine oxidase: four roles for the enzyme in rheumatoid pathology. , 1997, Biochemical Society transactions.

[6]  S. Sakuma,et al.  Peroxynitrite induces the conversion of xanthine dehydrogenase to oxidase in rabbit liver. , 1997, Biochemical and biophysical research communications.

[7]  A. Valenzuela,et al.  Changes in the xanthine dehydrogenase/xanthine oxidase ratio in the rat kidney subjected to ischemia-reperfusion stress: preventive effect of some flavonoids. , 1992, Research communications in chemical pathology and pharmacology.

[8]  J. Gollan,et al.  Enhanced activity of the free radical producing enzyme xanthine oxidase in hypoxic rat liver. Regulation and pathophysiologic significance. , 1991, The Journal of clinical investigation.

[9]  R. Cundall,et al.  Effects of hypoxia and reoxygenation on the conversion of xanthine dehydrogenase to oxidase in Chinese hamster V79 cells. , 1991, Free radical biology & medicine.

[10]  B. Freeman,et al.  Circulating xanthine oxidase: potential mediator of ischemic injury. , 1990, The American journal of physiology.

[11]  E. Corey,et al.  Antiarthritic gold compounds effectively quench electronically excited singlet oxygen. , 1987, Science.

[12]  D. Geltner,et al.  Gold-induced ileitis. , 1986, Journal of clinical gastroenterology.

[13]  P. Keown,et al.  Monocyte dependent excited oxygen radical generation in rheumatoid arthritis: inhibition by gold sodium thiomalate. , 1983, The Journal of rheumatology.

[14]  N L Gottlieb,et al.  Comparison of the kinetics of parenteral and oral gold. , 1983, Scandinavian journal of rheumatology. Supplement.

[15]  J. Thompson,et al.  Gold-induced thrombocytopenia. , 1978, The Journal of rheumatology.

[16]  J. Sharp,et al.  Comparison of two dosage schedules of gold salts in the treatment of rheumatoid arthritis. Relationship of serum gold levels to therapeutic response. , 1977, Arthritis and rheumatism.

[17]  K. Rajagopalan,et al.  The mechanism of conversion of rat liver xanthine dehydrogenase from an NAD+-dependent form (type D) to an O2-dependent form (type O). , 1976, Archives of biochemistry and biophysics.

[18]  W. Baumgartner,et al.  Clinical application for heavy metal-complexing potential of N-acetylcysteine. , 1973, Journal of clinical pharmacology.

[19]  F. Stirpe,et al.  The regulation of xanthine oxidase. Inhibition by reduced nicotinamide-adenine dinucleotide of rat liver xanthine oxidase type D and of chick liver xanthine dehydrogenase. , 1970, The Biochemical journal.

[20]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.